Redefining T2D and Obesity Management with GIP/GLP-1 receptor agonist

Time: 16:15 - 17:00
Hall: Congress Hall

Chair: Prof. Dr. med Martin Haluzik

Prof. Dr. med Martin Haluzik (Prague, Czech Republic) - The Need for proactive, comprehensive treatment of T2D and Obesity

Prof. Dr. med Tomasz Klupa (Kraków, Poland) - Targeting Adiposity as a Root Cause for T2D and Obesity

Prof. Dr. med Laxmi Narsimha Rao Bondugulapati (Abu Dhabi, UAE) - New Horizons in Obesity Care

Prof. Dr. med Tomasz Klupa (Kraków, Poland) - Incretin co-agonists in the Treatment of T2D

Panel Discussion

Treatment of cardiovascular continuum 2024: focus on novel opportunities

Time: 13:00 - 14:30
Hall: Congress Hall

Chair: R. Češka

L. Tokgözoğlu (Ankara, Turkey) - How to get to LDL-C goal in the multimorbid patients?

A. Zambon (Padova, Italy) - Beyond the usual suspects: TG-rich lipoproteins and Lp(a)

K. Narkiewicz (Gdansk, Poland) - The silent killers: Advanced strategies for hypertension and obesity management

Invitation for symposium here

The many faces of B12-deficiency and necessity of multidisciplinary management

Time: 14:30 - 15:30
Hall: South Hall 1

R. Češka (Prague, Czech Republic) - Optimizing Patient Care: Strategies for Managing Vitamin B12 Deficiency in Internal Medicine

R. Obeid (Hamburg, Germany) - Practical Guidance for Diagnosing and Treating Vitamin B12 Deficiency: Results of an International and Multidisciplinary B12 Consensus Conference

B. Hooshmand (Tutzing, Germany) - Vitamin B12 in Neurology: A Clinical Approach

Invitation for the symposium here

Comprehensive management of post ACS patients – how to improve and optimize secondary prevention?

Time: 15:30 - 16:30
Hall: Panorama Hall

Chair: R. Češka

A. Linhart (Prague, Czech Republic) - Dyslipidemia - an underappreciated risk factor in the context of a high-risk country

M. Vrablík (Prague, Czech Republic) - Fail no more. Lipid goals at our hands.

M. Kaluzna-Oleksy (Poznan, Poland) - Complex ACS management - the place of lipid lowering therapy and rehabilitation – learnings from MACAMIS program in Poland - ACS forum like an experience exchange platform

Time: 15:30 - 16:30
Hall: South Hall 1

C. Arias (Santo Domingo, Dominican Republic) - Monkeypox

Q. T. Islam (Dhaka, Bangladesh) - Emergencies in Dengue Syndrome

A. C. Cejudo (Mexico City, Mexico) - Inflammatory process and the risk factors for cardiovascular diseases

E. Topinková (Prague, Czech Republic) - Geriatrics

From Science to Practice: Optimizing Lipid Lowering Therapies for Cardiovascular Risk Reduction.

Time: 13:00 - 14:30
Hall: Congress Hall

Chair: R. Češka

R. Češka (Prague, Czech Republic) - Introduction

L. Tokgözoğlu (Ankara, Turkey) - CV risk reduction with lipid lowering: When and how?

M. Vrablík (Prague, Czech Republic) - The Power of Low LDL-C: Who Benefits Most and How Low is Enough

A. Zambon (Padova, Italy) - From research to clinical settings: PCSK9i Real Life Experience in Europe

Invitation for the symposium here